Isaac: Non-Invasive Blood Glucose Monitoring Tool With Breath Analysis Introduced At CES 2025

Isaac, a revolutionary device designed to monitor blood glucose levels without requiring a finger stab. (photo: x @raqamitv)

JAKARTA In the CES 2025 event, PreEVnt, a subsidiary of Scosche Industries, introduced Isaac, a revolutionary device designed to monitor blood glucose levels without requiring a finger puncture. This small, finger-entangled device combines state-of-the-art sensors with user-friendly applications, offering an innovative approach to diabetes management.

Isaac is designed for individuals with type 1, type 2, prediabetes, or those who want to monitor metabolic health. Using patent technology from Nanoz, the device detects acetone, a volatile organic compound in breath, to measure glucose levels.

The shape of Isaac is simple but futuristic: a white round electronic device with a circular metal face, a perforated design, and a small green light at the bottom.

Like a service dog trained to detect glycemic episodes, Isaac provides real-time feedback to its users. The companion app, which is available for iOS and Android, allows users to track and share blood glucose reports with caregivers or medical professionals. Users can also customize notifications and warnings to take timely action.

This device can be recharged and able to last all day in one charge, making it ideal for use many times every day.

The inspiration behind Isaac comes from the inventor's personal story. This device was developed to reduce dependence on traditional glucose monitoring methods that often hurt, such as fingers. The story of the discovery's grandson's struggle, diagnosed with type 1 diabetes at the age of two, is the main boost in the development of this device.

The five-year research support with Indiana University made Isaac a potential solution to bridge the gap in blood glucose monitoring, providing an easier and more convenient alternative for many.

Currently, Isaac is still in the FDA review stage and is not yet available for sale in the United States. This process ensures that the device meets security standards and strict effectiveness. After qualifying, Isaac is expected to increase consumer confidence and become a leading solution in diabetes management.